Trulicity, there are many similarities but also a few important differences
weight loss accelerates 72w 72 Weeks Average 20.9% body weight lost at 15 mg dose in SURMOUNT-1 trial Eligibility Who Qualifies BMI of 30 or higher (obesity classification) BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea No personal or family history of medullary thyroid cancer No history of multiple endocrine neoplasia syndrome type 2 Not currently pregnant, planning pregnancy, or breastfeeding No prior severe allergic reaction to tirzepatide Your Program Common Side Effects Most side effects are gastrointestinal, mild to moderate in severity, and tend to resolve as your body adjusts during the first several weeks
Helps improve the appearance of uneven skin tone
With this in mind, an emerging consumer base will attract attention, namely retired GLP-1 users, as they can experience semaglutide withdrawal symptoms and weight gain which may require a unique set of solutions
Such studies help clarify how complex biological systems respond to peptide-based interventions under controlled experimental conditions